Frequent hemoglobin (Hgb) monitoring (12x/month) can inform clinical and organisational decision making

Authors

Michael Germain MD, Baystate Health
Warren Ho MD, Baystate Health
Jane Garb, Baystate HealthFollow

Author Department

Medicine

Document Type

Presentations, Research

Publication Date

4-1-2008

Recommended Citation

Germain M, Ho W, Garb J, Bartlett C, Will E. Frequent hemoglobin (Hgb) monitoring (12x/month) can inform clinical and organisational decision making. National Kidney Foundation Clinical Meeting. Dallas, TX. Apr 2-Apr 8, 2008.